Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker
Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker
Cathie Wood led Ark Invest on Wednesday initiated a position in $Moderna(MRNA.US)$ after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide stronger protection against the Omicron variant than its current shot.
凱西·伍德領頭方舟 投資週三提出了一個職位，$Moderna(MRNA.US)$此前，這家生物技術公司表示，其更新版本的新冠肺炎加強疫苗似乎比目前的疫苗對奧密克戎變異病毒提供了更強的保護。
St. Petersburg, Florida-based Ark Invest bought 172,939 shares, estimated to be worth $25.68 million, in Moderna.
總部位於佛羅裏達州聖彼得堡的Ark Invest在Moderna購買了172,939股票，估計價值2,568萬美元。
Moderna closed 2.2% higher at $148.5 on Wednesday. The stock, which is down 36.8% so far this year, has risen 9% in the past month.
Moderna週三收高2.2%，報148.5美元。該股今年迄今下跌36.8%，過去一個月上漲9%。
Ark Invest bought the Moderna shares via its flagship pharma-linked exchange fund Ark Genomic Revolution ETF (BATS: ARKG) on Wednesday.
方舟投資通過其旗艦製藥關聯交易所基金購買了Moderna的股票方舟基因革命ETF(蝙蝠：ARKG)週三。
See Also: Moderna's Updated COVID-19 Shot Boosts Omicron Protection
另見：Moderna更新新冠肺炎推送奧密克戎保護
The money managing firm, however, sold 152,823 shares — estimated to be worth $8.17 million — in rival Pfizer Inc (NYSE: PFE) on Wednesday.
然而，這家資金管理公司在競爭對手手中出售了152,823股--估計價值817萬美元輝瑞(紐約證券交易所代碼：PFE)週三。
Shares of the biotech firm, which is boosting production of its oral COVID-19 pill, closed 0.9% lower at $53.4. The stock is down 5.6% year-to-date. Pfizer has been seeking FDA approval for three COVID-19 vaccine doses for children under five.
這家生物科技公司正在提高其口頭新冠肺炎口服藥的產量，其股價收盤下跌0.9%，至53.4美元。今年到目前為止，該股下跌了5.6%。輝瑞公司一直在尋求FDA批准為五歲以下兒童接種三劑新冠肺炎疫苗。
Ark Invest held 732, 993 shares, worth $39.5 million, in Pfizer before Wednesday's trade. The investment firm has been selling shares in Pfizer for months now.
週三交易前，Ark Invest持有輝瑞732,993股，價值3,950萬美元。這家投資公司幾個月來一直在出售輝瑞的股票。